Shruthi Satish, PhD

Shruthi Satish, PhD has a diverse work experience spanning various roles in the medical and scientific field. Shruthi is currently serving as the Medical Director at Synchrony Group, LLC since May 2023. Prior to this, they worked at 21GRAMS where they held the positions of Director, Medical Strategy from November 2021 to April 2023, and Associate Director, Medical Strategy from November 2021 to October 2022. Before joining 21GRAMS, they served as a Medical Director at Cadent Medical Communications from July 2021 to October 2021. Shruthi also worked as a Senior Medical Writer at SciStrategy Communications from March 2020 to July 2021, and as an Analyst at bioStrategies Group from November 2019 to March 2020. Shruthi started their career as a Research Scientist at Celprogen from January 2013 to July 2015.

Shruthi Satish, PhD, has a comprehensive education history in the field of biological sciences. After completing their Bachelor of Science degree in Biotechnology at Mount Carmel College, Ohio, from 2004 to 2007, they pursued further studies and obtained a Master of Science degree in Biotechnology from Vellore Institute of Technology between 2007 and 2009. Following their master's degree, they attended the University of California, Riverside from 2009 to 2012, completing a Master of Science degree in Molecular Biology. Lastly, Shruthi Satish pursued their Doctor of Philosophy (PhD) degree in Infectious Diseases at Rutgers University from 2015 to 2019, further specializing in their field of interest.